<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cision Wire</title>
    <link>http://news.cision.com/</link>
    <description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description>
    <pubDate>Thu, 20 Jun 2013 07:30:52 GMT</pubDate>
    <image>
      <title>Cision Wire</title>
      <width>120</width>
      <height>32</height>
      <link>http://news.cision.com/</link>
      <url>http://news.cision.com/ui/images/CisionLogoSmall.gif</url>
    </image>
    <item>
      <title>Families of SMA and Nationwide Children’s Announce Multi-Million Dollar Award from NINDS to Advance CNS Gene Therapy for Spinal Muscular Atrophy</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-sma-and-nationwide-children-s-announce-multi-million-dollar-award-from-ninds-to-advance-,c9384964</link>
      <guid isPermaLink="false">cision1271394</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Wed, 13 Mar 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Pfizer Licenses Families of Spinal Muscular Atrophy Quinazoline Drug Program from Repligen</title>
      <link>http://news.cision.com/families-of-sma/r/pfizer-licenses-families-of-spinal-muscular-atrophy-quinazoline-drug-program-from-repligen,c9353557</link>
      <guid isPermaLink="false">cision1209946</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Thu, 03 Jan 2013 14:15:39 GMT</pubDate>
    </item>
    <item>
      <title>Families of Spinal Muscular Atrophy Committed $2.5 Million to Funding SMA Research in 2012</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-spinal-muscular-atrophy-committed--2-5-million-to-funding-sma-research-in-2012,c9353171</link>
      <guid isPermaLink="false">cision1208870</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Mon, 31 Dec 2012 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Families of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapies</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-spinal-muscular-atrophy-awards--710-000-for-basic-research-to-identify-new-and-more-effe,c9352963</link>
      <guid isPermaLink="false">cision1208625</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Fri, 28 Dec 2012 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Repligen Initiates Phase 1b Trial of RG3039 for Spinal Muscular Atrophy Licensed from Families of SMA</title>
      <link>http://news.cision.com/families-of-sma/r/repligen-initiates-phase-1b-trial-of-rg3039-for-spinal-muscular-atrophy-licensed-from-families-of-sm,c9310419</link>
      <guid isPermaLink="false">cision1125342</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 26 Sep 2012 20:08:42 GMT</pubDate>
    </item>
    <item>
      <title>Families of SMA Announces $1.4 Million Planned for Next Round of Spinal Muscular Atrophy Research Funding.</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-sma-announces--1-4-million-planned-for-next-round-of-spinal-muscular-atrophy-research-fu,c9270541</link>
      <guid isPermaLink="false">cision504889</guid>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 07 Jun 2012 19:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Families of SMA Announces $700,000 Funding for Novel Drug Program at Newly Created California Institute for Biomedical Research.</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-sma-announces--700-000-funding-for-novel-drug-program-at-newly-created-california-instit,c9258810</link>
      <guid isPermaLink="false">cision492574</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Thu, 10 May 2012 19:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Families of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophy</title>
      <link>http://news.cision.com/families-of-sma/r/families-of-sma-awards-new-funding-to-advance-a-cns-delivered-gene-therapy-for-spinal-muscular-atrop,c9254738</link>
      <guid isPermaLink="false">cision488353</guid>
      <description><![CDATA[<p ><strong></strong>&nbsp;</p>]]></description>
      <pubDate>Wed, 02 May 2012 20:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Repligen Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA).</title>
      <link>http://news.cision.com/families-of-sma/r/repligen-reports-positive-results-from-phase-1-clinical-trial-for-spinal-muscular-atrophy--sma-,c9251546</link>
      <guid isPermaLink="false">cision484670</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Wed, 25 Apr 2012 14:23:22 GMT</pubDate>
      <media:content url="http://news.cision.com/families-of-sma/i/fsma-logo,c1208615" type="" />
    </item>
    <item>
      <title>Update on the Spinal Muscular Atrophy Drug Development Pipeline from Families of SMA</title>
      <link>http://news.cision.com/families-of-sma/r/update-on-the-spinal-muscular-atrophy-drug-development-pipeline-from-families-of-sma,c9208761</link>
      <guid isPermaLink="false">cision440867</guid>
      <description><![CDATA[<p ><strong></strong></p>]]></description>
      <pubDate>Thu, 19 Jan 2012 15:00:00 GMT</pubDate>
      <media:content url="http://news.cision.com/families-of-sma/i/2012-fsma-drug-pipeline,c142516" type="" />
    </item>
  </channel>
</rss>